Continuous isoproterenol inhalation therapy in children with severe asthmatic attack.
We studied the 1-type isoproterenol inhalation therapy for patients with severe asthmatic attacks who were admitted at the Department of Allergy of National Children's Hospital from 1981 to 1991. One hour after l-type isoproterenol inhalation therapy, statistically significant effects were noted with regard to the asthmatic status. Moreover, no side effect was found amoung the subjects. From these data, 1-type isoproterenol inhalation therapy is thought to be effective for severe asthmatic attacks.
Iikura
Y
Y
Department of Pediatrics, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan.
Matsumoto
T
T
Fujita
K
K
Otsuka
T
T
Sakamoto
Y
Y
Yun
S K
SK
Saito
H
H
Obata
T
T
Akasawa
A
A
Capulong
M C
MC
Sakaguchi
N
N
Oya
Y
Y
Tahara
K
K
Tachimoto
H
H
Kawahara
H
H
Koya
N
N
D000280:Administration, Inhalation; D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D007545:Isoproterenol / Q000008:administration & dosage*
D000318:Adrenergic beta-Agonists; D007545:Isoproterenol